
Liraglutide Peptide Therapy
Benefits, Side Effects, Cost & Protocols
Liraglutide, sold under the brand names Victoza and Saxenda, is a GLP-1 receptor agonist used to treat type 2 diabetes and chronic obesity. It is given by subcutaneous injection and was one of the first GLP-1 agonists approved for weight management.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Compare Liraglutide Prices
1 provider offering Liraglutide — sorted lowest price first
Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.
Who Is Liraglutide Best For?
How Liraglutide Works
GLP-1 receptor agonist that mimics incretin hormones to regulate appetite, slow gastric emptying, and improve blood sugar control.
Liraglutide FAQ
What is LIRAGLUTIDE?
Liraglutide is a first-generation GLP-1 receptor agonist used for weight management (Saxenda) and type 2 diabetes (Victoza). Developed by Novo Nordisk, it requires daily injection and has shown cardiovascular risk reduction benefits.
How does LIRAGLUTIDE work?
GLP-1 receptor agonist that mimics incretin hormones to regulate appetite, slow gastric emptying, and improve blood sugar control.
Is LIRAGLUTIDE legal to buy?
LIRAGLUTIDE requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.
Where can I buy LIRAGLUTIDE?
LIRAGLUTIDE is available by prescription through compounding pharmacies and telehealth providers. Browse our verified provider directory to find trusted sources.
What category does LIRAGLUTIDE belong to?
LIRAGLUTIDE is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.
What are the research benefits of LIRAGLUTIDE?
LIRAGLUTIDE has been studied for: Weight management, Blood sugar regulation, Cardiovascular risk reduction, Appetite suppression. First-generation daily GLP-1 agonist. Marketed as Saxenda (weight loss) and Victoza (diabetes).
Key Studies
5,640 total on PubMed0Liraglutide and Renal Outcomes in Type 2 Diabetes
Mann JFE, Ørsted DD, Brown-Frandsen K et al
N Engl J MedRCT
Liraglutide reduced risk of diabetic kidney disease progression and macroalbuminuria development
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso SP, Daniels GH, Brown-Frandsen K et al
N Engl J MedRCT
Liraglutide reduced cardiovascular death, MI, or stroke by 13% in type 2 diabetes
Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes
GRADE Study Research Group, Nathan DM, Lachin JM et al
N Engl J MedRCT
Liraglutide and glargine were more effective than glimepiride and sitagliptin at maintaining target hemoglobin A1c.
Liraglutide and glargine were more effective than glimepiride and sitagliptin at maintaining target hemoglobin A1c
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Liraglutide Compound Data
Liraglutide News
Liraglutide attenuates autoimmune myocarditis by inhibiting NLRP3 and NF-κb pathways - Nature
Nature · 9 months ago
FDA Approves First Generic GLP-1 Liraglutide for Weight Loss - Drug Topics
Drug Topics · 8 months ago
Quality Considerations in Solid Phase Peptide Synthesis: A Case Study with Liraglutide - fda.gov
fda.gov · 60 months ago
Lupin GLP-1 plans gets booster dose as FDA approves Liraglutide generic - ETPharma.com
ETPharma.com · 9 months ago
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER - American Heart Association Journals
American Heart Association Journals · 23 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore Liraglutide with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Liraglutide.
Take the Quiz →